Coumadin and Glutamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Coumadin (warfarin sodium) and Glutamine (glutamine). Common drug interactions include osteomyelitis chronic among females and renal tubular necrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Coumadin and Glutamine. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Coumadin?

Coumadin has active ingredients of warfarin sodium. It is often used in blood clots. eHealthMe is studying from 133,228 Coumadin users. Check the latest studies of Coumadin.

What is Glutamine?

Glutamine has active ingredients of glutamine. It is often used in muscle building therapy. eHealthMe is studying from 2,705 Glutamine users. Check the latest studies of Glutamine.



On Jul, 11, 2026

42 people who take Coumadin and Glutamine together, and have interactions are studied.

Coumadin and Glutamine drug interactions.

What are the common drug interactions of Coumadin and Glutamine, by gender? *:

female:

  1. Osteomyelitis chronic (long lasting infection of bone marrow)
  2. Pain in jaw
  3. Palpitations (feelings or sensations that your heart is pounding or racing)
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Urinary tract infection
  6. Mass
  7. Renal cancer (cancer of kidney)
  8. Fatigue (feeling of tiredness)
  9. Back pain
  10. Renal failure (kidney dysfunction)

male:

  1. Renal tubular necrosis (death of kidney tubules)
  2. Abdominal pain lower
  3. Overdose
  4. Platelet count decreased
  5. Pyrexia (fever)
  6. Weakness
  7. White blood cell count decreased
  8. Cardiomegaly (increased size of heart than normal)
  9. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  10. Deafness

What are the common drug interactions of Coumadin and Glutamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Arthralgia (joint pain)
  2. Decreased appetite
  3. Dry skin
  4. Erythema (redness of the skin)
  5. Fatigue (feeling of tiredness)
  6. Headache (pain in head)
  7. Hypokalaemia (low potassium)
  8. Oral discomfort (pain or irritation in mouth)
  9. Pain of skin
  10. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)

20-29:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Cardiac failure congestive
  3. Influenza like illness
  4. Urinary tract infection
  5. Cholecystitis (infection of gallbladder)
  6. Insomnia (sleeplessness)
  7. Intracardiac thrombus (presence of a circumscribed mass with heart wall)
  8. Tuberculin test positive
  9. Presyncope
  10. Mass

30-39:

n/a

40-49:

  1. Back pain
  2. Fatigue (feeling of tiredness)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
  5. Oedema peripheral (superficial swelling)
  6. Pain
  7. Renal atrophy (wasting of kidney)
  8. Renal failure (kidney dysfunction)
  9. Urinary retention (the inability to completely or partially empty the bladder)
  10. Lung neoplasm (tumour of lung)

50-59:

  1. Disease progression
  2. Influenza

60+:

  1. Adverse drug reaction
  2. Arthralgia (joint pain)
  3. Platelet count decreased
  4. Pneumonia
  5. Pyrexia (fever)
  6. Rash
  7. Abdominal pain lower
  8. Carbohydrate antigen 125 increased
  9. Cardiomegaly (increased size of heart than normal)
  10. Cellulitis (infection under the skin)

What are the existing conditions these people have? *

  1. Breast Cancer: 9 people, 21.43%
  2. Metastases To Bone (cancer spreads to bone): 8 people, 19.05%
  3. Breast Cancer Metastatic: 8 people, 19.05%
  4. Tumor: 3 people, 7.14%
  5. Retroperitoneal Cancer (cancer between the peritoneum and the posterior abdominal wall): 3 people, 7.14%
  6. Multiple Myeloma (cancer of the plasma cells): 3 people, 7.14%
  7. Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 3 people, 7.14%
  8. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Coumadin and Glutamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Coumadin and Glutamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Coumadin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glutamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Coumadin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glutamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium and glutamine (the active ingredients of Coumadin and Glutamine, respectively), and Coumadin and Glutamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: